Get the Stockscreener App
37.53
0.19%
0.07
After Hours:
37.53
Indivior Pharmaceuticals Inc stock is traded at $37.53, with a volume of 1.06M.
It is up +0.19% in the last 24 hours and up +12.40% over the past month.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
See More
Previous Close:
$37.46
Open:
$37.25
24h Volume:
1.06M
Relative Volume:
0.42
Market Cap:
$4.44B
Revenue:
$1.29B
Net Income/Loss:
$251.00M
P/E Ratio:
19.01
EPS:
1.9744
Net Cash Flow:
$-193.86M
1W Performance:
+2.09%
1M Performance:
+12.40%
6M Performance:
+14.60%
1Y Performance:
+234.79%
1-Day Range:
$37.20
$37.71
1-Week Range:
$35.80
$38.41
52-Week Range:
$11.08
$41.00
Indivior Pharmaceuticals Inc Stock (INDV) Company Profile
Name
Indivior Pharmaceuticals Inc
Sector
Phone
804-379-1090
Address
10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD
Compare INDV vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Pharmaceuticals Inc
|
37.53 | 4.43B | 1.29B | 251.00M | -193.86M | 1.9744 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Initiated | H.C. Wainwright | Buy |
| Jul-22-25 | Resumed | Jefferies | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
View All
Indivior Pharmaceuticals Inc Stock (INDV) Latest News
Free cash flow of Indivior Pharmaceuticals, Inc. – GETTEX:E7P - TradingView
Equity in earnings of Indivior Pharmaceuticals, Inc. – GETTEX:E7P - TradingView
Indivior Pharmaceuticals, Inc. Revenue Breakdown – GETTEX:E7P - TradingView
Bears are losing control over Indivior Pharmaceuticals Inc. (INDV), here's why it's a 'buy' now - MSN
Does Indivior Pharmaceuticals Inc. (INDV) have the potential to rally 32.48% as Wall Street analysts expect? - MSN
Does Indivior Pharmaceuticals Inc. (INDV) Have the Potential to Rally 32.48% as Wall Street Analysts Expect? - Yahoo Finance
Indivior launches $175M accelerated share buyback - MSN
Indivior (INDV) Shows Benefits of Sublocade for Opioid Use Disor - GuruFocus
Debt to assets ratio of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Price to cash flow ratio of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Preferred dividends of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Revenue Breakdown – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Income Statement – MUN:E7P - TradingView
Book value per share of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Earnings and Revenue – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Balance Sheet – MUN:E7P - TradingView
New Studies Show Adherence to Monthly Injectable - GlobeNewswire
The Bull Case For Indivior Pharmaceuticals (INDV) Could Change Following Upgraded Outlook And $175M BuybackLearn Why - Yahoo Finance
Assessing Indivior Pharmaceuticals (INDV) Valuation After Strong Long Term Share Price Momentum - Sahm
Indivior Pharmaceuticals Inc. (INDV) upgraded to strong buy: Here's what you should know - MSN
Indivior Pharmaceuticals Inc. (INDV) is a great choice for 'trend' investors, here's why - MSN
BMRN Stock Down on Mixed Results From Rare Disease Therapy Study - TradingView
INDV News | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill
Indivior Pharmaceuticals Inc. (INDV) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Indivior Pharmaceuticals Inc. (INDV) Q1 earnings and revenues beat estimates - MSN
Indivior Pharmaceuticals, Inc.Common Stock (Nasdaq:INDV) Stock Quote - The Chronicle-Journal
Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership - The Globe and Mail
Suboxone Tooth Decay Lawsuit Settlement May 2026 Update - Lawsuit Information Center
Indivior PLC stock (US45580R1068): earnings momentum and rising EPS estimates attract attention - AD HOC NEWS
Indivior (NASDAQ: INDV) ends CSO role and reports 2026 shareholder vote outcomes - Stock Titan
Madison Avenue entities (INDV) disclose 4.32M-share, ~3.5% stake - Stock Titan
Bears are Losing Control Over Indivior Pharmaceuticals Inc. (INDV), Here's Why It's a 'Buy' Now - Yahoo Finance
Indivior to Participate in Upcoming Investor Conferences - GlobeNewswire
Naloxone Market to See Booming Growth 2026-2033 | EMERGENT, Indivior PLC, Akorn, Inc - openPR.com
Indivior’s CEO lines up June investor meetings in New York and Miami - Stock Titan
Fuller & Thaler Asset Mgmt (NASDAQ: INDV) holds 4.53M shares, 3.72% - Stock Titan
Number of shareholders of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView
Why One Fund Made a $23 Million Bet on This Addiction-Treatment Stock Amid a Staggering Rally - AOL.com
Net income before discontinued operations of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Equity in earnings of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Working capital per share of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Indivior Pharmaceuticals, Inc. Balance Sheet – TRADEGATE:E7P - TradingView
Indivior Pharmaceuticals, Inc. Income Statement – TRADEGATE:E7P - TradingView
BDTX Shares Gain 11% in a Week: Here's What You Should Know - TradingView
State of New Jersey Common Pension Fund D Raises Stock Position in Indivior PLC $INDV - MarketBeat
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Strong Recent Share Price Run - Yahoo Finance
Vanguard Group Inc. Acquires 2,008,078 Shares of Indivior PLC $INDV - MarketBeat
Indivior Pharmaceuticals Inc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):